Cetuximab-induced skin exanthema: prophylactic and reactive skin therapy are equally effective.
about
Antibiotic prophylaxis for skin toxicity induced by antiepidermal growth factor receptor agents: a systematic review and meta-analysis.Update of cetuximab for non-melanoma skin cancer.Placebo-controlled phase II study of vitamin K3 cream for the treatment of cetuximab-induced rash.Dermatux: phase IV trial of Cetuximab plus FOLFIRI in first-line metastatic colorectal cancer receiving a pre-defined skin care.A Fusion Receptor as a Safety Switch, Detection, and Purification Biomarker for Adoptive Transferred T Cells.Chimeric Monoclonal Antibody Cetuximab Targeting Epidermal Growth Factor-Receptor in Advanced Non-Melanoma Skin Cancer.
P2860
Cetuximab-induced skin exanthema: prophylactic and reactive skin therapy are equally effective.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 07 August 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Cetuximab-induced skin exanthe ...... therapy are equally effective.
@en
Cetuximab-induced skin exanthe ...... therapy are equally effective.
@nl
type
label
Cetuximab-induced skin exanthe ...... therapy are equally effective.
@en
Cetuximab-induced skin exanthe ...... therapy are equally effective.
@nl
prefLabel
Cetuximab-induced skin exanthe ...... therapy are equally effective.
@en
Cetuximab-induced skin exanthe ...... therapy are equally effective.
@nl
P2093
P2860
P1476
Cetuximab-induced skin exanthe ...... therapy are equally effective.
@en
P2093
Carl C Schimanski
Claudine Graf
Hauke Lang
Ines Gockel
Jutta Herzog
Markus Möhler
Martin R Berger
Matthias Theobald
Peter R Galle
Thomas C Wehler
P2860
P2888
P304
P356
10.1007/S00432-013-1483-4
P577
2013-08-07T00:00:00Z